209 related articles for article (PubMed ID: 23335178)
21. PAX1 methylation as a robust predictor: developing and validating a nomogram for assessing endocervical curettage (ECC) necessity in human papillomavirus16/18-positive women undergoing colposcopy.
Lu Y; Wu H; Fu K; Shen Y; Li L; Liao Z; Liu Y; Kang Y; Zhang Y
Clin Epigenetics; 2024 Jun; 16(1):77. PubMed ID: 38849868
[TBL] [Abstract][Full Text] [Related]
22. Quantitative Measurement of L1 Human Papillomavirus Type 16 Methylation for the Prediction of Preinvasive and Invasive Cervical Disease.
Kottaridi C; Kyrgiou M; Pouliakis A; Magkana M; Aga E; Spathis A; Mitra A; Makris G; Chrelias C; Mpakou V; Paraskevaidis E; Panayiotides JG; Karakitsos P
J Infect Dis; 2017 Mar; 215(5):764-771. PubMed ID: 28170039
[TBL] [Abstract][Full Text] [Related]
23. Quantitative measurement of Human Papillomavirus type 16 L1/L2 DNA methylation correlates with cervical disease grade.
Bryant D; Tristram A; Liloglou T; Hibbitts S; Fiander A; Powell N
J Clin Virol; 2014 Jan; 59(1):24-9. PubMed ID: 24268385
[TBL] [Abstract][Full Text] [Related]
24. Risk stratification of HPV 16 DNA methylation combined with E6 oncoprotein in cervical cancer screening: a 10-year prospective cohort study.
Dong L; Zhang L; Hu SY; Feng RM; Zhao XL; Zhang Q; Pan QJ; Zhang X; Qiao YL; Zhao FH
Clin Epigenetics; 2020 May; 12(1):62. PubMed ID: 32381054
[TBL] [Abstract][Full Text] [Related]
25. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
26. Lower cost strategies for triage of human papillomavirus DNA-positive women.
Qiao YL; Jeronimo J; Zhao FH; Schweizer J; Chen W; Valdez M; Lu P; Zhang X; Kang LN; Bansil P; Paul P; Mahoney C; Berard-Bergery M; Bai P; Peck R; Li J; Chen F; Stoler MH; Castle PE
Int J Cancer; 2014 Jun; 134(12):2891-901. PubMed ID: 24248915
[TBL] [Abstract][Full Text] [Related]
27. A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes.
Brentnall AR; Vasiljević N; Scibior-Bentkowska D; Cadman L; Austin J; Szarewski A; Cuzick J; Lorincz AT
Int J Cancer; 2014 Sep; 135(6):1425-32. PubMed ID: 24535756
[TBL] [Abstract][Full Text] [Related]
28. Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women.
Hesselink AT; Heideman DA; Steenbergen RD; Coupé VM; Overmeer RM; Rijkaart D; Berkhof J; Meijer CJ; Snijders PJ
Clin Cancer Res; 2011 Apr; 17(8):2459-65. PubMed ID: 21389098
[TBL] [Abstract][Full Text] [Related]
29. [Performance of combined liquid based cytology and HPV nucleic acid test for detecting cervical precancer among women attending screening].
Jiang MY; Feng RM; Wang L; Li TY; Zhang AA; Cui JF; Pan QJ; Zhang X; Liu ML; Gao F; Chen W; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):750-756. PubMed ID: 30392339
[No Abstract] [Full Text] [Related]
30. Human Papillomavirus Test for Triage of Japanese Women With Low-Grade Squamous Intraepithelial Lesions.
Iwata T; Hasegawa T; Ochiai K; Takizawa K; Umezawa S; Kuramoto H; Ohmura M; Kubushiro K; Arai H; Sakamoto M; Motoyama T; Watanabe K; Aoki D
Reprod Sci; 2015 Dec; 22(12):1509-15. PubMed ID: 26092278
[TBL] [Abstract][Full Text] [Related]
31. High-risk human papillomavirus E6/E7 mRNA and L1 DNA as markers of residual/recurrent cervical intraepithelial neoplasia.
Persson M; Brismar Wendel S; Ljungblad L; Johansson B; Weiderpass E; Andersson S
Oncol Rep; 2012 Jul; 28(1):346-52. PubMed ID: 22484610
[TBL] [Abstract][Full Text] [Related]
32. The increased detection of cervical intraepithelial neoplasia when using a second biopsy at colposcopy.
van der Marel J; van Baars R; Rodriguez A; Quint WG; van de Sandt MM; Berkhof J; Schiffman M; Torné A; Ordi J; Jenkins D; Verheijen RH; Helmerhorst TJ; Ter Harmsel B; Wentzensen N; Del Pino M
Gynecol Oncol; 2014 Nov; 135(2):201-7. PubMed ID: 25204846
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus (HPV) E6/E7 mRNA as a triage test after detection of HPV 16 and HPV 18 DNA.
Perez Castro S; Iñarrea Fernández A; Lamas González MJ; Sarán Diez MT; Cid Lama A; Alvarez Martín MJ; Pato Mosquera M; López-Miragaya I; Estévez N; Torres Piñón J; Oña Navarro M
J Med Virol; 2013 Jun; 85(6):1063-8. PubMed ID: 23588733
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic value of human papillomavirus (HPV) 16 and HPV18 viral loads for the detection of high-grade cervical intraepithelial neoplasia (CIN2+) in a cohort of African women living with HIV.
Segondy M; Ngou J; Kelly H; Omar T; Goumbri-Lompo O; Doutre S; Mayaud P; Didelot MN
J Clin Virol; 2018; 99-100():79-83. PubMed ID: 29353074
[TBL] [Abstract][Full Text] [Related]
35. Assessment of the effectiveness of HPV16/18 infection referred for colposcopy in cervical cancer screening in Northwest of China.
Zhang Q; Zhao M; Cao D; Wei X; Wang L; Li Y; Yang T; Zhao J; Pei M; Jia H; Cao S; Quan S; Yang X
J Med Virol; 2018 Jan; 90(1):165-171. PubMed ID: 28710863
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus 16 load and E2/E6 ratio in HPV16-positive women: biomarkers for cervical intraepithelial neoplasia >or=2 in a liquid-based cytology setting?
Boulet GA; Benoy IH; Depuydt CE; Horvath CA; Aerts M; Hens N; Vereecken AJ; Bogers JJ
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2992-9. PubMed ID: 19861526
[TBL] [Abstract][Full Text] [Related]
37. Physical and methylation status of human papillomavirus 16 in asymptomatic cervical infections changes with malignant transformation.
Dutta S; Chakraborty C; Dutta AK; Mandal RK; Roychoudhury S; Basu P; Panda CK
J Clin Pathol; 2015 Mar; 68(3):206-11. PubMed ID: 25563334
[TBL] [Abstract][Full Text] [Related]
38. Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology-screened referral population.
Leeman A; Del Pino M; Marimon L; Torné A; Ordi J; Ter Harmsel B; Meijer CJLM; Jenkins D; Van Kemenade FJ; Quint WGV
Int J Cancer; 2019 Jan; 144(1):160-168. PubMed ID: 30098013
[TBL] [Abstract][Full Text] [Related]
39. DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort.
van Leeuwen RW; Oštrbenk A; Poljak M; van der Zee AGJ; Schuuring E; Wisman GBA
Int J Cancer; 2019 Feb; 144(4):746-754. PubMed ID: 30259973
[TBL] [Abstract][Full Text] [Related]
40. Clinical Value of Human Papillomavirus E6/E7 mRNA Detection in Screening for Cervical Cancer in Women Positive for Human Papillomavirus DNA or.
Han L; Husaiyin S; Zhao F; Rezhake R; Niyazi M
Clin Lab; 2018 Sep; 64(9):1363-1371. PubMed ID: 30274003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
